Life Science Tools and Services
2025Fiscal year
Companies 37
Median of average pay per registered director · KRW 207 million
| Company | Notes | ||||
|---|---|---|---|---|---|
| Olix Pharmaceuticals | KRW 186 million | KRW 759 million | 5 | 76 | |
| Ngenebio | KRW 155 million | KRW 137 million | 4 | 56 | |
| Seegene | KRW 97 million | KRW 727 million | 4 | 822 | |
| CJ Bioscience | KRW 88 million | KRW 312 million | 2 | 50 | Filer note attached |
| Curiox Biosystems | KRW 72 million | KRW 81 million | 3 | 22 | |
| Intron Biotechnology | KRW 65 million | KRW 281 million | 3 | 77 | |
| Quanta Matrix | KRW 64 million | KRW 285 million | 3 | 67 | |
| Aligned Genetics | KRW 62 million | KRW 224 million | 3 | 40 | |
| HL Bbio Step | KRW 62 million | KRW 416 million | 4 | 150 | Denominator mismatch flagged |
| Oncocross | KRW 61 million | KRW 260 million | 3 | 40 | |
| Macrogen | KRW 60 million | KRW 369 million | 4 | 488 | |
| CG Invites | KRW 60 million | KRW 54 million | 6 | 92 | |
| Nanoentek | KRW 60 million | KRW 84 million | 3 | 93 | |
| Bio Infra | KRW 59 million | KRW 190 million | 3 | 141 | |
| Labgenomics | KRW 58 million | KRW 88 million | 3 | 142 | |
| Ilshin Biobase | KRW 57 million | KRW 371 million | 3 | 37 | |
| Osang Healthcare | KRW 57 million | KRW 337 million | 3 | 336 | |
| P&K Skin Research Center | KRW 56 million | KRW 278 million | 3 | 23 | |
| Precision Biosensor | KRW 55 million | KRW 116 million | 3 | 97 | |
| Tomocube | KRW 55 million | KRW 174 million | 2 | 76 | Filer note attached |
| Choolip Science | KRW 54 million | KRW 360 million | 6 | 44 | |
| GC Genome | KRW 51 million | KRW 312 million | 3 | 131 | |
| HLB Panagene | KRW 51 million | KRW 75 million | 6 | 84 | |
| Boditech Med | KRW 50 million | KRW 345 million | 2 | 601 | |
| IM Bdx | KRW 50 million | KRW 193 million | 4 | 65 | |
| Daihan Scientific | KRW 49 million | KRW 141 million | 4 | 120 | |
| Ivim Technology | KRW 49 million | KRW 119 million | 3 | 37 | |
| Curiosis | KRW 48 million | KRW 207 million | 3 | 93 | |
| Humasis | KRW 48 million | KRW 76 million | 3 | 64 | |
| DT&CRO | KRW 47 million | KRW 246 million | 2 | 314 | |
| Biotoxtech | KRW 47 million | KRW 285 million | 3 | 241 | |
| KBT | KRW 47 million | KRW 130 million | 4 | 127 | |
| NK Gen Biotech Korea | KRW 44 million | KRW 104 million | 3 | 70 | |
| JS Link | KRW 44 million | KRW 191 million | 6 | 139 | |
| Eone Diagnomics Genome Center | KRW 44 million | KRW 112 million | 2 | 63 | |
| Access Bio | Foreign-incorporated listing | Foreign-incorporated listing | 5 | 75 | |
| Psomagen | Foreign-incorporated listing | Foreign-incorporated listing | 2 | 88 | Filer note attached |
Before reading this table
- Figures collect the filed per-person averages without transformation, and can differ from totals divided by headcounts.
- Listed filers only, and consolidated subsidiaries' staff are not included.
- These are filed values whose accuracy the source institution does not guarantee.
- Company rows reproduce each filer's own reported values without transformation, and this site computes none of them.
- Where few registered directors are covered, the per-person average approaches a few individuals' pay.
- Sharing an industry code does not mean doing the same work.
- Filed values on the wrong digit scale are converted to a common basis against the company's own filings in other years, and where no basis exists the reason shows instead of an amount.
- Classifications with thin samples publish no median or weighted industry figure, while the employee average is shown regardless of sample size alongside the company count.
Industry groupings and names follow Naver Finance's sector classification. The per-company figures themselves reproduce annual-report filings.